Phenylketonuria (PKU) is a rare hereditary condition in which the amino acid phenylalanine is not properly metabolized. PKU can cause severe mental retardation if not treated.
Causes, incidence, and risk factors
Phenylketonuria (PKU) is inherited as an autosomal recessive trait (both parents must pass on the defective gene for the child to be affected). The genetically determined abnormality in phenylketonuria is a missing enzyme called phenylalanine hydroxylase. Phenylalanine is one of the eight essential amino acids found in protein-containing foods. In PKU, phenylalanine cannot be used in a normal fashion because of the missing enzyme. Subsequently, high levels of phenylalanine and two closely related phenylalanine derivatives build up in the body. These compounds are toxic to the central nervous system and cause brain damage.
Damage to the brain causes marked mental retardation by the end of the first year of life if the offending proteins are not scrupulously avoided. Older children may develop movement disorders ( athetosis ), rocking and hyperactivity . PKU is a treatable disease that can be easily detected by a simple blood test. Most states require a screening test for all newborns, generally done with a heelstick shortly after birth. Because phenylalanine is involved indirectly in the production of melanin , the pigment responsible for skin and hair color, children with phenylketonuria often have lighter complexions than their unaffected siblings. There is a characteristic "mousy" odor that results from the accumulation of phenylacetic acid. This odor may be detected on their breath, skin, and urine if the condition has not been treated immediately from birth or if foods containing phenylalanine are consumed.
Treatment
Treatment includes a diet that is extremely low in phenylalanine ; particularly when the child is growing. Strict compliance to the diet is necessary to prevent or minimize mental retardation . This requires close supervision by a registered dietitian or physician, and cooperation of the parent(s) and child.
Phenylalanine occurs in significant amounts in milk, eggs and other common foods. Nutrasweet (aspartame) also contains phenylalanine, and products containing aspartame should be avoided by children with this disorder. A special infant formula called Lofenalac is made for infants with PKU. It can be used throughout life as a protein source that is extremely low in phenylalanine and balanced for the remaining essential amino acids .
Adult women who have PKU and who plan to become pregnant should also adhere to a strict low-phenylalanine diet both before becoming pregnant and throughout the pregnancy.
Expectations (prognosis)
The outcome is expected to be very good if dietary treatment is followed closely beginning shortly after the child's birth. If treatment is started after 3 years or if the disorder remains untreated, brain damage is inevitable.
Complications
Severe mental retardation occurs if the disorder is untreated.
Calling your health care provider
Call your health care provider if your infant has not been tested for PKU. This is particularly important if anyone in your family has the disorder.
Prevention
Genetic counseling is recommended for prospective parents with a family history of PKU. The carrier state for PKU can be detected by enzyme assays, and PKU can be diagnosed prenatally. It is imperative that women with PKU who becomes pregnant adhere closely to the special low-phenylalanine diet, since accumulation of phenylalanine will damage the unborn baby even if the baby has not inherited the abnormality.